These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 17075807

  • 1. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
    Tseng CE, Buyon JP, Kim M, Belmont HM, Mackay M, Diamond B, Marder G, Rosenthal P, Haines K, Ilie V, Abramson SB.
    Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
    [Abstract] [Full Text] [Related]

  • 2. Steroid therapy in clinically stable but serologically active systemic lupus erythematosus prevents severe disease flares.
    Cardiel MH, Almagro RM.
    Expert Rev Clin Immunol; 2007 May; 3(3):267-9. PubMed ID: 20477670
    [Abstract] [Full Text] [Related]

  • 3. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR, Sato EI.
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [Abstract] [Full Text] [Related]

  • 4. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
    Vieira CS, Pereira FV, de Sá MF, Paulo LJ, Martins WP, Ferriani RA.
    Maturitas; 2009 Mar 20; 62(3):311-6. PubMed ID: 19193505
    [Abstract] [Full Text] [Related]

  • 5. Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.
    Cardiel MH, Tumlin JA, Furie RA, Wallace DJ, Joh T, Linnik MD, LJP 394-90-09 Investigator Consortium.
    Arthritis Rheum; 2008 Aug 20; 58(8):2470-80. PubMed ID: 18668592
    [Abstract] [Full Text] [Related]

  • 6. Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up.
    Liao YN, Liu CS, Tsai TR, Hung YC, Chang SJ, Lin HL, Chen YC, Lai HM, Yu SF, Chen CJ.
    Kaohsiung J Med Sci; 2011 Jul 20; 27(7):251-7. PubMed ID: 21757141
    [Abstract] [Full Text] [Related]

  • 7. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA, van Vollenhoven RF, Buyon J, Levy RA, Navarra SV, Cervera R, Zhong ZJ, Freimuth WW, BLISS-52 and BLISS-76 Study Groups.
    Arthritis Rheum; 2013 Aug 20; 65(8):2143-53. PubMed ID: 23754628
    [Abstract] [Full Text] [Related]

  • 8. Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosus.
    Tew GW, Rabbee N, Wolslegel K, Hsieh HJ, Monroe JG, Behrens TW, Brunetta PG, Keir ME.
    Lupus; 2010 Feb 20; 19(2):146-57. PubMed ID: 19946034
    [Abstract] [Full Text] [Related]

  • 9. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
    Ng KP, Manson JJ, Rahman A, Isenberg DA.
    Arthritis Rheum; 2006 Dec 15; 55(6):900-4. PubMed ID: 17139667
    [Abstract] [Full Text] [Related]

  • 10. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
    Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE.
    Arthritis Rheum; 2004 Sep 15; 50(9):2858-68. PubMed ID: 15452837
    [Abstract] [Full Text] [Related]

  • 11. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG, Martensson U, Sturfelt G.
    J Rheumatol; 1997 May 15; 24(5):871-8. PubMed ID: 9150075
    [Abstract] [Full Text] [Related]

  • 12. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Petri MA, Lahita RG, Van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, Strand V, Kunz A, Gorelick KJ, Schwartz KE, GL601 Study Group.
    Arthritis Rheum; 2002 Jul 15; 46(7):1820-9. PubMed ID: 12124866
    [Abstract] [Full Text] [Related]

  • 13. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
    Chang DM, Lan JL, Lin HY, Luo SF.
    Arthritis Rheum; 2002 Nov 15; 46(11):2924-7. PubMed ID: 12428233
    [Abstract] [Full Text] [Related]

  • 14. Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies?
    Esdaile JM, Joseph L, Abrahamowicz M, Li Y, Danoff D, Clarke AE.
    J Rheumatol; 1996 Nov 15; 23(11):1891-6. PubMed ID: 8923362
    [Abstract] [Full Text] [Related]

  • 15. Measurement of clinical activity of systemic lupus erythematosus and laboratory abnormalities: a 12-month prospective study.
    Zonana-Nacach A, Salas M, Sánchez ML, Camargo-Coronel A, Bravo-Gatica C, Mintz G.
    J Rheumatol; 1995 Jan 15; 22(1):45-9. PubMed ID: 7699680
    [Abstract] [Full Text] [Related]

  • 16. Flares in lupus: Outcome Assessment Trial (FLOAT), a comparison between oral methylprednisolone and intramuscular triamcinolone.
    Danowski A, Magder L, Petri M.
    J Rheumatol; 2006 Jan 15; 33(1):57-60. PubMed ID: 16395750
    [Abstract] [Full Text] [Related]

  • 17. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 15; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 18. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.
    Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, Hua B, Liu B, Ye S, Hu X, Xu W, Zeng X, Hou Y, Gilkeson GS, Silver RM, Lu L, Shi S.
    Arthritis Rheum; 2010 Aug 15; 62(8):2467-75. PubMed ID: 20506343
    [Abstract] [Full Text] [Related]

  • 19. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M, Canadian Network For Improved Outcomes in Systemic Lupus.
    Arthritis Rheum; 2008 Dec 15; 59(12):1796-804. PubMed ID: 19035431
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study.
    Petri M, Singh S, Tesfasyone H, Malik A.
    J Rheumatol; 2009 Nov 15; 36(11):2476-80. PubMed ID: 19833757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.